Most cited published in 2022

• 230

  2021 ESC/EACTS Guidelines for the management of valvular heart disease: Developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS)

  Alec Vahanian, Friedhelm Beyersdorf, Fabien Praz, Milan Milojevic, Stephan Baldus, Johann Bauersachs, Davide Capodanno, Lenard Conradi, Michele De Bonis, Ruggero De Paulis, Victoria Delgado, Nick Freemantle, Martine Gilard, Kristina H. Haugaa, Anders Jeppsson, Peter Jüni, Luc Pierard, Bernard D. Prendergast, J. Rafael Sádaba, Christophe Tribouilloy, Wojtek Wojakowski, ESC/EACTS Scientific Document Group

  Rev Esp Cardiol. 2022;75:524

• 134

  2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: Developed by the Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC) With the special contribution of the Heart Failure Association (HFA) of the ESC

  Theresa A. McDonagh, Marco Metra, Marianna Adamo, Roy S. Gardner, Andreas Baumbach, Michael Böhm, Haran Burri, Javed Butler, Jelena Čelutkienė, Ovidiu Chioncel, John G.F. Cleland, Andrew J.S. Coats, Maria G. Crespo-Leiro, Dimitrios Farmakis, Martine Gilard, Stephane Heymans, Arno W. Hoes, Tiny Jaarsma, Ewa A. Jankowska, Mitja Lainscak, Carolyn S.P. Lam, Alexander R. Lyon, John J.V. McMurray, Alexandre Mebazaa, Richard Mindham, Claudio Muneretto, Massimo Francesco Piepoli, Susanna Price, Giuseppe M.C. Rosano, Frank Ruschitzka, Anne Kathrine Skibelund, ESC Scientific Document Group

  Rev Esp Cardiol. 2022;75:523

• 2

  Impact of a cardiology consultation integrated with primary care in the follow-up of patients with chronic heart disease

  Raquel Pimienta González, Elena Pérez Cánovas, Zita Morales Rodríguez, Alejandro Quijada Fumero, Celestino Hernández García, Julio Salvador Hernández Afonso

  Rev Esp Cardiol. 2022;75:612-4

• 2

  Smartwatches and ischemic heart disease. A future possibility?

  Mauro Buelga Suárez, Jesús García Montalvo, Gonzalo Luis Alonso Salinas

  Rev Esp Cardiol. 2022;75:764

• 2

  Comments on the 2021 ESC/EACTS guidelines for the management of valvular heart disease

  SEC Working Group for the 2021 ESC/EACTS guidelines for the management of valvular heart disease and SEC Guidelines Committee

  Rev Esp Cardiol. 2022;75:466-71

• 2

  Fabry cardiomyopathy: parametric mapping adds even more

  Virginia Ruiz Pizarro, Jorge Álvarez Rubio, María Jesús Soleto Roncero, Tomás Ripoll-Vera

  Rev Esp Cardiol. 2022;75:845-7

• 1

  High-density lipoprotein cholesterol: a new marker in heart failure

  Carlos G. Santos-Gallego, Juan Antonio Requena-Ibáñez, Juan José Badimón

  Rev Esp Cardiol. 2022;75:855-7

• 1

  Cost-effectiveness of transcatheter aortic valve implants in 2022

  Manuel Martínez-Sellés

  Rev Esp Cardiol. 2022;75:853

• 1

  No-reflow phenomenon in STEMI: beyond a good angiographic result

  Rafael Cobas Paz, Berenice Caneiro Queija, Andrés Íñiguez Romo

  Rev Esp Cardiol. 2022;75:706-8

• 1

  Correction in the article «Declaración PRISMA 2020: una guía actualizada para la publicación de revisiones sistemáticas», Rev Esp Cardiol. 2021;74:790-799

  Rev Esp Cardiol. 2022;75:192